Chief of Neurology, Director of Center for Human Genomics, Founding Director Bryan Alzheimer's Research Center
Active years
1971-1998
Degrees
BS Pittsburgh. MD PennsylvaniaChief of neurology for 27 years, he was a co-discoverer of the Apo-E gene's role in Alzheimer's Disease and the TOMM40 gene as a target for Alzheimer's therapies. He left Duke to lead worldwide genetics research at Glaxo Wellcome for ten years, but returned to Duke.